• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The production in vivo of microcin E492 with antibacterial activity depends on salmochelin and EntF.具有抗菌活性的微菌素E492在体内的产生依赖于沙门菌素和EntF。
J Bacteriol. 2008 Aug;190(15):5464-71. doi: 10.1128/JB.00351-08. Epub 2008 May 23.
2
Insight into siderophore-carrying peptide biosynthesis: enterobactin is a precursor for microcin E492 posttranslational modification.对携带铁载体肽生物合成的洞察:肠杆菌素是微菌素E492翻译后修饰的前体。
Antimicrob Agents Chemother. 2007 Oct;51(10):3546-53. doi: 10.1128/AAC.00261-07. Epub 2007 Jul 23.
3
The Ferric uptake regulator (Fur) and iron availability control the production and maturation of the antibacterial peptide microcin E492.铁摄取调节因子(Fur)和铁可用性控制抗菌肽微菌素 E492 的产生和成熟。
PLoS One. 2018 Aug 2;13(8):e0200835. doi: 10.1371/journal.pone.0200835. eCollection 2018.
4
The expression of genes involved in microcin maturation regulates the production of active microcin E492.参与微菌素成熟的基因表达调控活性微菌素E492的产生。
Biochimie. 2002 May-Jun;84(5-6):539-44. doi: 10.1016/s0300-9084(02)01415-3.
5
Structure, organization and characterization of the gene cluster involved in the production of microcin E492, a channel-forming bacteriocin.与形成通道的细菌素微菌素E492产生相关的基因簇的结构、组织及特性分析
Mol Microbiol. 2001 Oct;42(1):229-43. doi: 10.1046/j.1365-2958.2001.02630.x.
6
Microcin e492 amyloid formation is retarded by posttranslational modification.微菌素 e492 淀粉样纤维的形成受到翻译后修饰的抑制。
J Bacteriol. 2013 Sep;195(17):3995-4004. doi: 10.1128/JB.00564-13. Epub 2013 Jul 8.
7
Cooperative uptake of microcin E492 by receptors FepA, Fiu, and Cir and inhibition by the siderophore enterochelin and its dimeric and trimeric hydrolysis products.受体FepA、Fiu和Cir对微菌素E492的协同摄取以及铁载体肠螯合素及其二聚体和三聚体水解产物的抑制作用。
Antimicrob Agents Chemother. 2005 Jul;49(7):3083-6. doi: 10.1128/AAC.49.7.3083-3086.2005.
8
Antibacterial and antitumorigenic properties of microcin E492, a pore-forming bacteriocin.小孔形成细菌素微菌素E492的抗菌和抗肿瘤特性
Curr Pharm Biotechnol. 2009 Jan;10(1):74-85. doi: 10.2174/138920109787048643.
9
Involvement of enterobactin synthesis pathway in production of microcin H47.肠杆菌素合成途径参与微菌素H47的产生。
Antimicrob Agents Chemother. 2004 Apr;48(4):1235-41. doi: 10.1128/AAC.48.4.1235-1241.2004.
10
Parasitism of iron-siderophore receptors of Escherichia coli by the siderophore-peptide microcin E492m and its unmodified counterpart.铁载体肽微菌素E492m及其未修饰对应物对大肠杆菌铁-铁载体受体的寄生作用
Biometals. 2006 Apr;19(2):181-91. doi: 10.1007/s10534-005-4452-9.

引用本文的文献

1
The Ferric uptake regulator (Fur) and iron availability control the production and maturation of the antibacterial peptide microcin E492.铁摄取调节因子(Fur)和铁可用性控制抗菌肽微菌素 E492 的产生和成熟。
PLoS One. 2018 Aug 2;13(8):e0200835. doi: 10.1371/journal.pone.0200835. eCollection 2018.
2
An Engineered Synthetic Pathway for Discovering Nonnatural Nonribosomal Peptides in .在. 中发现非天然非核糖体肽的工程合成途径。
mBio. 2017 Oct 10;8(5):e01474-17. doi: 10.1128/mBio.01474-17.
3
Identification of Key Amino Acid Residues Modulating Intracellular and In vitro Microcin E492 Amyloid Formation.调节细胞内和体外微小菌素E492淀粉样蛋白形成的关键氨基酸残基的鉴定
Front Microbiol. 2016 Jan 28;7:35. doi: 10.3389/fmicb.2016.00035. eCollection 2016.
4
Microcin e492 amyloid formation is retarded by posttranslational modification.微菌素 e492 淀粉样纤维的形成受到翻译后修饰的抑制。
J Bacteriol. 2013 Sep;195(17):3995-4004. doi: 10.1128/JB.00564-13. Epub 2013 Jul 8.
5
Microbial manipulation of the amyloid fold.微生物对淀粉样折叠的操控。
Res Microbiol. 2012 Nov-Dec;163(9-10):592-606. doi: 10.1016/j.resmic.2012.10.009. Epub 2012 Oct 27.

本文引用的文献

1
Biosynthetic tailoring of microcin E492m: post-translational modification affords an antibacterial siderophore-peptide conjugate.微菌素E492m的生物合成修饰:翻译后修饰产生一种抗菌的铁载体 - 肽共轭物。
J Am Chem Soc. 2007 Nov 21;129(46):14336-47. doi: 10.1021/ja074650f. Epub 2007 Oct 31.
2
Siderophore-based iron acquisition and pathogen control.基于铁载体的铁获取与病原体控制。
Microbiol Mol Biol Rev. 2007 Sep;71(3):413-51. doi: 10.1128/MMBR.00012-07.
3
Insight into siderophore-carrying peptide biosynthesis: enterobactin is a precursor for microcin E492 posttranslational modification.对携带铁载体肽生物合成的洞察:肠杆菌素是微菌素E492翻译后修饰的前体。
Antimicrob Agents Chemother. 2007 Oct;51(10):3546-53. doi: 10.1128/AAC.00261-07. Epub 2007 Jul 23.
4
Comparative analysis of chromosome-encoded microcins.染色体编码微菌素的比较分析
Antimicrob Agents Chemother. 2006 Apr;50(4):1411-8. doi: 10.1128/AAC.50.4.1411-1418.2006.
5
A protein interaction surface in nonribosomal peptide synthesis mapped by combinatorial mutagenesis and selection.通过组合诱变和筛选绘制的非核糖体肽合成中的蛋白质相互作用表面
Proc Natl Acad Sci U S A. 2006 Apr 4;103(14):5314-9. doi: 10.1073/pnas.0601038103. Epub 2006 Mar 27.
6
How pathogenic bacteria evade mammalian sabotage in the battle for iron.致病细菌如何在争夺铁的战斗中规避哺乳动物的破坏。
Nat Chem Biol. 2006 Mar;2(3):132-8. doi: 10.1038/nchembio771.
7
In vitro characterization of salmochelin and enterobactin trilactone hydrolases IroD, IroE, and Fes.沙门菌素和肠杆菌素三内酯水解酶IroD、IroE和Fes的体外特性研究
J Am Chem Soc. 2005 Aug 10;127(31):11075-84. doi: 10.1021/ja0522027.
8
Functions of the siderophore esterases IroD and IroE in iron-salmochelin utilization.铁载体酯酶IroD和IroE在利用铁沙门菌素中的作用。
Microbiology (Reading). 2005 Jul;151(Pt 7):2363-2372. doi: 10.1099/mic.0.27888-0.
9
Cooperative uptake of microcin E492 by receptors FepA, Fiu, and Cir and inhibition by the siderophore enterochelin and its dimeric and trimeric hydrolysis products.受体FepA、Fiu和Cir对微菌素E492的协同摄取以及铁载体肠螯合素及其二聚体和三聚体水解产物的抑制作用。
Antimicrob Agents Chemother. 2005 Jul;49(7):3083-6. doi: 10.1128/AAC.49.7.3083-3086.2005.
10
Amyloid formation modulates the biological activity of a bacterial protein.淀粉样蛋白的形成调节细菌蛋白的生物活性。
J Biol Chem. 2005 Jul 22;280(29):26880-5. doi: 10.1074/jbc.M502031200. Epub 2005 May 25.

具有抗菌活性的微菌素E492在体内的产生依赖于沙门菌素和EntF。

The production in vivo of microcin E492 with antibacterial activity depends on salmochelin and EntF.

作者信息

Mercado Gabriela, Tello Mario, Marín Macarena, Monasterio Octavio, Lagos Rosalba

机构信息

Departamento de Biología, Facultad de Ciencias, Universidad de Chile, Casilla 653, Santiago, Chile.

出版信息

J Bacteriol. 2008 Aug;190(15):5464-71. doi: 10.1128/JB.00351-08. Epub 2008 May 23.

DOI:10.1128/JB.00351-08
PMID:18502859
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2493280/
Abstract

Microcin E492 is a channel-forming bacteriocin that is found in two forms, namely, a posttranslationally modified form obtained by the covalent linkage of salmochelin-like molecules to serine 84 and an unmodified form. The production of modified microcin E492 requires the synthesis of enterochelin, which is subsequently glycosylated by MceC and converted into salmochelin. mceC mutants produced inactive microcin E492, and this phenotype was reversed either by complementation with iroB from Salmonella enterica or by the addition of exogenous salmochelin. Cyclic salmochelin uptake by Escherichia coli occurred mainly through the outer membrane catecholate siderophore receptor Fiu. The production of inactive microcin E492 by mutants in entB and entC was reverted by the addition of the end product of the respective mutated pathway (2,3-dihydroxybenzoic acid and enterochelin/salmochelin, respectively), while mutants in entF did not produce active microcin E492 in the presence of enterochelin or salmochelin. The EntF adenylation domain was the only domain required for this microcin E492 maturation step. Inactivation of the enzymatic activity of this domain by site-directed mutagenesis did not prevent the synthesis of active microcin E492 in the presence of salmochelin, indicating that the adenylation activity is not essential for the function of EntF at this stage of microcin E492 maturation.

摘要

微菌素E492是一种形成通道的细菌素,它有两种形式,即通过类沙门菌素样分子与丝氨酸84共价连接获得的翻译后修饰形式和未修饰形式。修饰后的微菌素E492的产生需要肠螯合素的合成,随后肠螯合素被MceC糖基化并转化为沙门菌素。mceC突变体产生无活性的微菌素E492,通过用肠炎沙门氏菌的iroB进行互补或添加外源性沙门菌素可逆转这种表型。大肠杆菌对环状沙门菌素的摄取主要通过外膜儿茶酚铁载体受体Fiu进行。entB和entC突变体产生的无活性微菌素E492通过添加各自突变途径的终产物(分别为2,3-二羟基苯甲酸和肠螯合素/沙门菌素)而恢复活性,而entF突变体在存在肠螯合素或沙门菌素的情况下不产生活性微菌素E492。EntF腺苷化结构域是微菌素E492成熟步骤所需的唯一结构域。通过定点诱变使该结构域的酶活性失活,在存在沙门菌素的情况下并不妨碍活性微菌素E492的合成,这表明在微菌素E492成熟的这个阶段,腺苷化活性对EntF的功能不是必需的。